Literature DB >> 1515794

Guillain-Barré syndrome after treatment with streptokinase.

D Barnes1, R A Hughes.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1515794      PMCID： PMC1881813          DOI： 10.1136/bmj.304.6836.1225-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Medicine and managers.

Authors:  C D Shaw
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

2.  Guillain-Barré syndrome after streptokinase therapy.

Authors:  M J Cicale
Journal:  South Med J       Date:  1987-08       Impact factor: 0.954

3.  Streptokinase and the Guillain-Barré syndrome.

Authors:  D A Leaf; I MacDonald; B Kliks; R Wilson; S R Jones
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

4.  Streptokinase and the Guillain-Barré syndrome.

Authors:  J B Arrowsmith; J B Milstien; J N Kuritsky; G Murano
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

5.  Possible association of Guillain-Barré syndrome with thrombolytic therapy.

Authors:  K V Eden
Journal:  JAMA       Date:  1983-04-15       Impact factor: 56.272
  5 in total
  4 in total

1.  Bilateral hypopyon and streptokinase.

Authors:  D Kinshuck
Journal:  BMJ       Date:  1992-11-28

2.  Guillain-Barré syndrome after rtPA therapy for acute stroke.

Authors:  A Bersano; D Santoro; A Prelle; S Lanfranconi; M Ranieri; C S Tadeo; N Bresolin; P L Baron
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

3.  Guillain-barré syndrome after thrombolysis with streptokinase.

Authors:  Ertugrul Okuyan; Mehmet Akif Cakar; Mustafa H Dinckal
Journal:  Cardiol Res Pract       Date:  2010-12-26       Impact factor: 1.866

Review 4.  Matrix and backstage: cellular substrates for viral vaccines.

Authors:  Ingo Jordan; Volker Sandig
Journal:  Viruses       Date:  2014-04-11       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.